BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 12562055)

  • 1. Overview and neurobiology of attention-deficit/hyperactivity disorder.
    Spencer TJ; Biederman J; Wilens TE; Faraone SV
    J Clin Psychiatry; 2002; 63 Suppl 12():3-9. PubMed ID: 12562055
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Structural and functional neuroanatomy of attention-deficit hyperactivity disorder (ADHD)].
    Emond V; Joyal C; Poissant H
    Encephale; 2009 Apr; 35(2):107-14. PubMed ID: 19393378
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Attention-deficit/hyperactivity disorder: a selective overview.
    Biederman J
    Biol Psychiatry; 2005 Jun; 57(11):1215-20. PubMed ID: 15949990
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Attention-deficit-hyperactivity disorder: an update.
    Dopheide JA; Pliszka SR
    Pharmacotherapy; 2009 Jun; 29(6):656-79. PubMed ID: 19476419
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurobiology of attention deficit hyperactivity disorder.
    Kieling C; Goncalves RR; Tannock R; Castellanos FX
    Child Adolesc Psychiatr Clin N Am; 2008 Apr; 17(2):285-307, viii. PubMed ID: 18295147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Attention deficit/hyperactivity disorder in adults.
    Moss SB; Nair R; Vallarino A; Wang S
    Prim Care; 2007 Sep; 34(3):445-73, v. PubMed ID: 17868755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Attention-deficit/hyperactivity disorder: diagnosis, lifespan, comorbidities, and neurobiology.
    Spencer TJ; Biederman J; Mick E
    J Pediatr Psychol; 2007 Jul; 32(6):631-42. PubMed ID: 17556405
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Neurobiology of attention deficit/hyperactivity disorder].
    Purper-Ouakil D; Lepagnol-Bestel AM; Grosbellet E; Gorwood P; Simonneau M
    Med Sci (Paris); 2010 May; 26(5):487-96. PubMed ID: 20510147
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Attention-deficit/hyperactivity disorder: diagnosis, lifespan, comorbidities, and neurobiology.
    Spencer TJ; Biederman J; Mick E
    Ambul Pediatr; 2007; 7(1 Suppl):73-81. PubMed ID: 17261486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overview of epidemiology, clinical features, genetics, neurobiology, and prognosis of adolescent attention-deficit/hyperactivity disorder.
    Schubiner H; Katragadda S
    Adolesc Med State Art Rev; 2008 Aug; 19(2):209-15, vii. PubMed ID: 18822827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Health-related quality of life in children and adolescents who have a diagnosis of attention-deficit/hyperactivity disorder.
    Klassen AF; Miller A; Fine S
    Pediatrics; 2004 Nov; 114(5):e541-7. PubMed ID: 15520087
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The epidemiology of attention-deficit/hyperactivity disorder (ADHD): a public health view.
    Rowland AS; Lesesne CA; Abramowitz AJ
    Ment Retard Dev Disabil Res Rev; 2002; 8(3):162-70. PubMed ID: 12216060
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictive validity of ICD-10 hyperkinetic disorder relative to DSM-IV attention-deficit/hyperactivity disorder among younger children.
    Lahey BB; Pelham WE; Chronis A; Massetti G; Kipp H; Ehrhardt A; Lee SS
    J Child Psychol Psychiatry; 2006 May; 47(5):472-9. PubMed ID: 16671930
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence, recognition, and treatment of attention-deficit/hyperactivity disorder in a national sample of US children.
    Froehlich TE; Lanphear BP; Epstein JN; Barbaresi WJ; Katusic SK; Kahn RS
    Arch Pediatr Adolesc Med; 2007 Sep; 161(9):857-64. PubMed ID: 17768285
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Etiologic classification of attention-deficit/hyperactivity disorder.
    Millichap JG
    Pediatrics; 2008 Feb; 121(2):e358-65. PubMed ID: 18245408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Poor utility of the age of onset criterion for DSM-IV attention deficit/hyperactivity disorder: recommendations for DSM-V and ICD-11.
    Todd RD; Huang H; Henderson CA
    J Child Psychol Psychiatry; 2008 Sep; 49(9):942-9. PubMed ID: 18564071
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnosing attention-deficit/hyperactivity disorder in patients with substance use disorders.
    Levin FR
    J Clin Psychiatry; 2007; 68 Suppl 11():9-14. PubMed ID: 18307376
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The heterogeneity of causes and courses of attention-deficit/hyperactivity disorder.
    Steinhausen HC
    Acta Psychiatr Scand; 2009 Nov; 120(5):392-9. PubMed ID: 19807721
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictive validity of DSM-IV and ICD-10 criteria for ADHD and hyperkinetic disorder.
    Lee SI; Schachar RJ; Chen SX; Ornstein TJ; Charach A; Barr C; Ickowicz A
    J Child Psychol Psychiatry; 2008 Jan; 49(1):70-8. PubMed ID: 17979965
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Review: Genetics of attention deficit/hyperactivity disorder.
    Wallis D; Russell HF; Muenke M
    J Pediatr Psychol; 2008; 33(10):1085-99. PubMed ID: 18522996
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.